# EDGAR Filing Document

**Accession Number:** 0001681622
**File Stem:** 0001681622-26-000040
**Filing Date:** 2026-3
**Character Count:** 12090
**Document Hash:** 090909894353076df63b28a37d8a54ca
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001681622-26-000040.hdr.sgml**: 20260326

**ACCESSION NUMBER**: 0001681622-26-000040

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20260213

**FILED AS OF DATE**: 20260326

**DATE AS OF CHANGE**: 20260326

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Garcia Victor Hugo
- **CENTRAL INDEX KEY:** 0002121644

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37860
- **FILM NUMBER:** 26800346

**MAIL ADDRESS:**
- **STREET 1:** 1678 S. PIONEER ROAD
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84104
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Varex Imaging Corp
- **CENTRAL INDEX KEY:** 0001681622
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRONIC COMPONENTS, NEC [3679]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 813434516
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1002

**BUSINESS ADDRESS:**
- **STREET 1:** 1678 S. PIONEER ROAD
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84104
- **BUSINESS PHONE:** 801-972-5000

**MAIL ADDRESS:**
- **STREET 1:** 1678 S. PIONEER ROAD
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84104

## Ex-24

![](exhibit24-garcia001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;Page 1 of 2 Exhibit 24 Power of Attorney I, Victor H. Garcia, hereby constitute and appoint Matthew Martinez, Sunny Sanyal, Shubham Maheshwari, Richard Ludlow, McKay Johnson and Brian Qualls, and each of them individually, as my true and lawful attorney-in-fact to: 1. Prepare, execute in my name and on my behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling me to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC. 2. Complete and execute on my behalf as an officer and/or director of Varex Imaging Corporation (the "Company") any Forms 3, 4, or 5, and any amendment thereto, required to be filed by me under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations thereunder. 3. Do and perform any and all acts for and on my behalf which may be necessary or desirable to complete any such Form 3, 4 or 5, and any amendment thereto, and timely file such form or amended form with the SEC and any stock exchange or similar authority; and 4. Take any other action of any type whatsoever in connection with the foregoing, which in the opinion of such attorney-in-fact may be of benefit to, in the best interest of, or legally required of me, it being understood that the documents executed by such attorney-in-fact on my behalf pursuant to this Power of Attorney shall be in such form and shall contain such information as such attorney-in-fact may approve in such attorney-in-fact's discretion. I hereby grant to each of such attorneys-in-fact full power and authority to do and perform any and every act which is necessary or desirable to be done in the exercise of any of the powers and authority granted in this Power of Attorney, with full power of substitution and revocation, and I ratify and confirm every act that such attorney-in-fact lawfully performs or causes to be done by virtue of this Power of Attorney and the powers and authority granted herein. I acknowledge that the attorneys-in-fact appointed in this Power of Attorney, in serving in such capacity at my request, are not assuming, and the Company is not assuming, any of my responsibilities to comply with Section 16 of the Securities and Exchange Act of 1934 or the rules or regulations thereunder. This Power of Attorney shall remain in full force and effect until I am no longer required to file Forms 3, 4 or 5 with respect to my holding or transactions in securities issued by the

------

![](exhibit24-garcia002.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;Page 2 of 2 Company, unless I earlier revoke this Power of Attorney in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has executed this power of attorney as of this 18th day of February 2026. /s/ Victor H. Garcia Victor H. Garcia

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Garcia Victor Hugo<br><sub>(Last) (First) (Middle)</sub><br>C/O VAREX IMAGING CORP,<br>1678 S. PIONEER ROAD<br><sub>(Street)</sub><br>SLC, UT 84104<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Varex Imaging Corp [ VREX ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-02-13 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_SVP, Regulatory and QA_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 23360 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 4970 | <sup>(2)</sup> | D |  |
| Restricted Stock Units | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 5079 | <sup>(2)</sup> | D |  |
| Restricted Stock Units | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 9190 | <sup>(2)</sup> | D |  |
| Restricted Stock Units | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 16666 | <sup>(2)</sup> | D |  |
| Performance Stock Units | <sup>(6)</sup> | <sup>(6)</sup> | Common Stock | 2673 | <sup>(7)</sup> | D |  |
| Performance Stock Units | <sup>(8)</sup> | <sup>(8)</sup> | Common Stock | 2004 | <sup>(7)</sup> | D |  |
| Non-Qualified Stock Option (right to buy) | <sup>(9)</sup> | 2026-02-15 | Common Stock | 11776 | $31.42 | D |  |
| Non-Qualified Stock Option (right to buy) | <sup>(10)</sup> | 2030-02-15 | Common Stock | 14013 | $28.12 | D |  |
| Non-Qualified Stock Option (right to buy) | <sup>(11)</sup> | 2031-02-16 | Common Stock | 13426 | $25.06 | D |  |
| Non-Qualified Stock Option (right to buy) | <sup>(12)</sup> | 2031-12-10 | Common Stock | 12427 | $30.95 | D |  |
| Non-Qualified Stock Option (right to buy) | <sup>(13)</sup> | 2032-12-08 | Common Stock | 20597 | $22.13 | D |  |

---

### Footnotes:

(1) These Restricted Stock Units granted on December 9, 2022 vested 50% on December 10, 2024, with the remaining 50% scheduled to vest on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date.

(2) Each Restricted Stock Unit converts into common stock on a one-for-one basis.

(3) These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date.

(4) These Restricted Stock Units granted on December 10, 2024 vest 50% on December 10, 2026 and 50% on December 10, 2028. Vested shares will be delivered to the reporting person upon vest date.

(5) These Restricted Stock Units granted on December 10, 2025 vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.

(6) On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned as a result of the achievement of such performance criteria for fiscal year 2024 and 2025. Following the completion of Fiscal Year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

(7) Each PSU represents a contingent right to receive one share of Issuer common stock, subject to the achievement of applicable performance criteria.

(8) On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of Fiscal Year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.

(9) These Non-Qualified Stock Options, granted on February 15, 2019 are subject to a four-year vesting schedule. 25% of the total number of options vested on February 15, 2020, with the remaining options vesting monthly thereafter on the 15th day of each month on a pro rata basis. These options expired unexercised on February15, 2026

(10) These Performance Stock Options, granted on February 18, 2020, are subject to a four-year vesting schedule. 25% of the total number of options vested on February 15, 2021, with the remaining options vesting monthly thereafter on the 15th day of each month on a pro rata basis.

(11) These Performance Stock Options, granted on February 16, 2021, are subject to a four-year vesting schedule. 25% of the total number of options vested on February 15, 2022, with the remaining options vesting monthly thereafter on the 15th day of each month on a pro rata basis.

(12) These Performance Stock Options, granted on December 10, 2021, are subject to a four-year vesting schedule. 25% of the total number of options vested on December 10, 2022, with the remaining options vesting monthly thereafter on the 10th day of each month on a pro rata basis.

(13) These Performance Stock Options, granted on December 9, 2022, are subject to a four-year vesting schedule. 25% of the total number of options vested on December 10, 2023, with the remaining options vesting monthly thereafter on the 10th day of each month on a pro rata basis.

**Signature:** /s/ Victor H. Garcia  
**Date:** 2026-03-25

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**